Compare Centratama Telekomunikasi Indonesia Tbk. (CENT) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centratama Telekomunikasi Indonesia Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Centratama Telekomunikasi Indonesia Tbk. trades at Rp83 (market cap 2.59T, 2.3M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Centratama Telekomunikasi Indonesia Tbk. is far larger — about 15.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Centratama Telekomunikasi Indonesia Tbk. is more actively traded (2.3M versus 187.4K). Which is the better fit depends on your goals.
| CENT | OBAT | |
|---|---|---|
Market Cap | 2.59T | 164.65B |
Volume | 2.3M | 187.4K |
Lot | 22.99K | 1.87K |
Turnover | 190.59M | 44.35M |
Average Price | 82.9 | 236.67 |
Value | 190.59M | 44.35M |
Indicative Equilibrium Price | 83 | 242 |
Indicative Equilibrium Volume | 201 | 500 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centratama Telekomunikasi Indonesia Tbk.
PT Centratama Telekomunikasi Indonesia Tbk formerly Centrin Online The corporate was established on February 11th 1987 in Bandung as PT. Centrindo Utama. Since the first establishment, corporate focus the business on the information technology. Start the operation in computer hardware sales such as supporting hardware and monitor which produced by PT. Central Rama Informatiko as a affiliated company. And start the internet service provider business on 1996.
Read more on CENT →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
